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The mitochondrial isoform of glycerol-3-phosphate 
acyltransferase (GPAT), the first step in glycerolipid syn­
thesis, is up-regulated by insulin and by high carbohy­
drate feeding via SREBP-lc, suggesting that it plays a role 
in triacylglycerol synthesis. To test this hypothesis, we 
overexpressed mitochondrial GPAT in Chinese hamster 
ovary (CHO) cells. When GPAT was overexpressed 3.8- 
fold, triacylglycerol mass was 2.7-fold higher than in con­
trol cells. After incubation with trace [14C]oleate (~3 /xm), 
control cells incorporated 4.7-fold more label into phos­
pholipid than triacylglycerol, but GPAT-overexpressing 
cells incorporated equal amounts of label into phospho­
lipid and triacylglyceroh In GPAT-overexpressing cells, 
the incorporation of label into phospholipid, particularly 
phosphatidylcholine, decreased 30%, despite normal 
growth rate and phospholipid content, suggesting that 
exogenous oleate was directed primarily toward triacyl­
glycerol synthesis. Transiently transfected HEK293 cells 
that expressed a 4.4-fold increase in GPAT activity incor­
porated 9.7-fold more [14C]oleate into triacylglycerol com­
pared with control cells, showing that the effect of GPAT 
overexpression was similar in two different cell types that 
had been transfected by different methods. When the sta­
ble, GPAT-overexpressing CHO cells were incubated with 
100 /xm oleate to stimulate triacylglycerol synthesis, they 
incorporated 1.9-fold more fatty acid into triacylglycerol 
than did the control cells. Confocal microscopy of CHO 
and HEK293 cells transfected with the GPAT-FLAG con­
struct showed that GPAT was located correctly in mito­
chondria and was not present elsewhere in the cell. These 
studies indicate that overexpressed mitochondrial GPAT 
directs incorporation of exogenous fatty acid into triacyl­
glycerol rather than phospholipid and imply that (a) mi­
tochondrial GPAT and lysophosphatidic acid acyltrans­
ferase produce a separate pool of lysophosphatidic acid 
and phosphatidic acid that must be transported to the 
endoplasmic reticulum where the terminal enzymes of 
triacylglycerol synthesis are located, and (6) this pool re­
mains relatively separate from the pool of lysophospha­
tidic acid and phosphatidic acid that contributes to the 
synthesis of the major phospholipid species.
Excess accumulation of triacylglycerol in adipocytes is a ma­
jor factor contributing to the current epidemic of obesity-re­
lated disorders, including type 2 diabetes, and excess accumu­
lation of triacylglycerol in non-adipocytes has been linked to 
lipid-mediated apoptosis (1, 2). Although obesity research has 
focused on the storage of calories that are ingested in excess of 
energy needs, the observation that mice null for diacylglycerol 
acyltransferase are resistant to diet-induced obesity suggests 
the possibility that, independent of energy intake or expendi­
ture, the amount of triacylglycerol stored can be regulated 
biochemically (3). This remarkable observation further sug­
gests that the synthesis of triacylglycerol can be specifically 
regulated and that regulation of the synthetic pathway could 
determine how much triacylglycerol is stored in cells. If this 
were true, enzymes in the biosynthetic pathway of triacylglyc­
erol synthesis could provide targets for therapy.
The pathway for triacylglycerol synthesis begins with the 
acylation of glycerol 3-phosphate at the S7i-1 position by glyc­
erol 3-phosphate acyltransferase (GPAT)1 (EC 2.3.1.15), the 
committed step for the synthesis of all glycerolipids. After 
acylation by GPAT to form lysophosphatidic acid, LPA acyl­
transferase acylates the sn-2 position to form phosphatidic 
acid, which is then hydrolyzed to form diacylglycerol. Phospha­
tidic acid is the precursor for the anionic phospholipids, phos­
phatidylinositol, phosphatidylglycerol, and cardiolipin, whereas 
diacylglycerol is the precursor for the quantitatively most prom­
inent phospholipids, phosphatidylcholine, phosphatidylethanol­
amine, and phosphatidylserine, as well as for triacylglycerol. 
Most of the enzymes required for these synthetic steps are lo­
cated in the endoplasmic reticulum, but LPA acyltransferase 
activity and a specific GPAT isoform are also located on the 
mitochondrial outer membrane (4).
The rate-limiting step of phosphatidylcholine synthesis, CT- 
P:phosphocholine cytidylyltransferase, undergoes complex 
post-translational regulation by membrane lipid composition, 
subcellular location, and phosphorylation state (5). It has been 
generally assumed that phospholipid synthesis is tightly regu­
lated in accordance with requirements for membrane turnover 
and cell proliferation (6), but that the synthesis of triacylglyc­
erol is controlled primarily by the amount of fatty acid avail­
able. Thus, triacylglycerol synthesis is enhanced only when 
fatty acid synthesis or uptake exceeds the cellular need for 
phospholipid synthesis. This view is supported by cell culture
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studies showing that when the concentration of media fatty 
acid is low, it is primarily incorporated into phospholipid, and 
when fatty acid concentration is high, the formation of triacyl­
glycerol is greatly favored (7, 8). In addition, overexpression of 
putative fatty acid transporters can increase triacylglycerol 
stores (9).
On the other hand, the view that triacylglycerol storage is 
unregulated is inconsistent with the observation that DGAT 
knockout mice remain slim on a high fat diet even though they 
are able to synthesize triacylglycerol by a DGAT-independent 
mechanism (3). Indirect evidence that triacylglycerol synthesis 
is regulated also comes from studies of the mitochondrial iso­
form of GPAT, which is transcriptionally controlled by diet 
changes that promote or depress the synthesis of triacylglyc­
erol. For example, carbohydrate feeding or high insulin concen­
trations increase liver GPAT mRNA, whereas fasting or lack of 
insulin down-regulates GPAT mRNA (10), probably via insulin- 
mediated regulation of SREBP-lc (11, 12). Mitochondrial 
GPAT mRNA is also elevated 12-fold in pancreatic /3-cells from 
obese diabetic Zucker fa!fa rats, implying a role for triacylg­
lycerol synthesis in the observed /3-cell steatosis (13). Acute 
GPAT regulation has also been reported in mitochondria; con­
sistent with the need to decrease triacylglycerol synthesis and 
increase energy-producing oxidation in the face of limited nu­
trients, 5-amino-4-imidazol ecarb oxamide riboside, a synthetic 
activator of AMP-activated kinase, the proposed sensor of cel­
lular fuel deprivation, acutely decreases GPAT activity (14).
Despite these data suggesting that mitochondrial GPAT reg­
ulates triacylglycerol synthesis in cells, this hypothesis has not 
been examined directly. To determine whether mitochondrial 
GPAT plays a specific role in triacylglycerol synthesis, we cre­
ated a stable cell line in which the expression of mitochondrial 
GPAT could be regulated.
EXPERIMENTAL PROCEDURES
Materials—Silica gel G plates were from Whatman. [2-3H] Glycerol 
and [1-14C] oleic acid were from PerkinElmer Life Sciences. Essentially 
fatty acid-free BSA, anti-FLAG M2 monoclonal antibody, and digitonin 
were from Sigma. Lipid standards were from Doosan Serdary Research 
Laboratories. Tissue culture supplies were from Corning, and culture 
medium and ultrafiltered FBS were obtained from Life Technologies, 
Inc.
Construction ofpBI-EGFP! GPAT-FLAG and Establishment of Dou­
ble-stable Transfected CHO Cell Line—GPAT with a FLAG epitope 
(DYKDDDDK) at the C terminus was constructed by adding the FLAG 
coding sequence by polymerase chain reaction amplification in a two- 
step procedure. The plasmid pcDNA3.1 containing the entire GPAT 
open reading frame flanked by Bum HI and Xhol sites was used as a 
template for the amplification. In the first step, the oligonucleotide 
(5'BamGPAT) ATCGCGGATCCACCATGGAGGAGT was used as the 5' 
primer, and the oligonucleotide CATCATCATCCTTGTAGTCGAG- 
CACGACGAAGCTGAGAATGTA (3'GPAT-F1), which adds 19 nucleo­
tides encoding the FLAG epitope (shown in bold), was used as the 
3'primer. The amplification product was used as a template for the 
second polymerase chain reaction step, using the same 5' primer and 
the 3' primer oligonucleotide CGCC TCTAGACTACTTGTCATCAT- 
CATCCTTGTAGTCGAGCA (3'Xba FL2), designed to add the last 5 
nucleotides corresponding to the FLAG epitope, a stop codon, and a 
Xbal restriction site. The resulting second amplification product was 
digested with BamRl and Xbal and inserted in the multicloning site of 
the plasmid pcDNA3.1 to generate pcDNA3.1-GPAT-FLAG. Mlul and 
Nhel sites flanking GPAT-FLAG were added by polymerase chain re­
action, and the amplified GPAT-FLAG product was subcloned into the 
mammalian expression vector pBI-EGFP-tet (CLONTECH), a bidirec­
tional response plasmid that allows simultaneous expression of both 
green fluorescent protein and GPAT-FLAG under the control of a single 
tetracycline (doxycycline)-responsive element. CHO cells were cotrans­
fected with the pBI-EGFP/GPAT-FLAG construct and a pTet-Off plas­
mid (CLONTECH), which expresses a hybrid protein and activates 
transcription in the absence of doxycycline. When doxycycline is pres­
ent, neither GPAT nor EGFP are expressed. To establish the double­
stable transfected cell line, CHO cells in 35-mm dishes were cotrans­
fected with pBI-EGFP/GPAT-FLAG (1 pg) and pTet-Off (2 pg) using 
Transfast transfection reagent (Promega). Twenty-four h after trans­
fection, cells were selected with 600 gg/ml G418 for 2 weeks. Positive 
GFP clones were identified under UV light microscopy and diluted into 
a 96-well plate. After continued selection with G418 for 6-8 weeks, 
lines were selected that expressed green fluorescent protein in 100% of 
the cells. Cells were routinely cultured in MEM with 10% heat-inacti­
vated FBS plus 100 units/ml penicillin and 100 gg/ml streptomycin 
(normal medium) at 34 °C, 5% CO2, and 100% humidity, in the presence 
or absence of doxycycline (2 pg/ml) to repress or induce, respectively, 
GPAT overexpression. The medium was changed every other day.
Transient transfection and immunocytochemical analysis of GPAT 
expression were performed as described previously (15) with modifica­
tions. CHO KI cells were trypsinized and seeded in 100-mm tissue 
culture dishes containing six to eight glass coverslips. The cells were 
incubated at 37 °C until 70% confluence and then transfected with 
cationic liposomes (LipofectAMINE, Life Technologies, Inc.) with 
pcDNA 3.1 vector alone or with pcDNA3.1-GPAT-FLAG. After 27 h cells 
were washed with PBS and incubated for 15 min with 0.1 pM Texas 
Red, a mitochondrial marker (Mito-tracker, Molecular Probes) in cul­
ture medium, rinsed with PBS, and fixed with 2% formaldehyde at room 
temperature for 10 min. After washing with PBS, cells were permeabi- 
lized with 5 gg/ml digitonin in buffer A (0.3 M sucrose, 25 mM MgCl2, 0.1 
M KC1, 1 mM EDTA, 10 mM PIPES buffer, pH 6.8) for 5 min on ice, 
incubated with a 1/1000 dilution of anti-FLAG M2 monoclonal antibody 
(Sigma) for 60 min, washed with PBS, and incubated for 45 min with a 
1/200 dilution of fluorescein isothiocyanate (FITC)-conj ugated second­
ary antibody: goat anti-mouse IgG (Santa Cruz Biotechnology). Cells 
were then washed in PBS, and the coverslips were mounted. Confocal 
microscopy was performed on a Zeiss LSH 210 fluorescence microscope 
equipped with excitation argon laser 488/514 to visualize cells stained 
with the Texas Red and FITC antibodies. Images were saved and 
analyzed using Photoshop v.5.5 and Image Processing Tool Kit to over­
lay multiband fluorescence images.
Total Particulate Preparations and Enzyme Assays—CHO cells that 
had been grown continuously in either the presence or absence of 
doxycycline were washed with PBS, scraped into Medium 1 (250 mM 
sucrose, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM dithiothreitol), homog­
enized with 10 up and down strokes in a Teflon-glass homogenizing 
vessel, and centrifuged at 100,000 x g for 1 h to obtain total particulate 
(membrane) fractions. GPAT activity was measured with 10-40 pg of 
protein after incubation for 15 min on ice in the absence (total GPAT) or 
presence (mitochondrial GPAT) of 2 mM N-ethylmaleimide. The 10-min 
assay at room temperature contained 2 mM [3H] glycerol 3-phosphate 
and 0.75 mM palmitoyl-CoA (16). Microsomal GPAT activity was calcu­
lated as total activity minus 2V-ethylmaleimide-resistant activity. Acyl- 
CoA synthetase activity was assayed using 1-5 pg of protein, 50 /¿mol 
of [14C] palmitic acid, 10 mM ATP, 5 mM dithiothreitol, and 0.25 mM CoA 
for 10 min at 37 °C (17). DGAT activity was assayed using 5-20 pg of 
protein, 0.2 mM sn-l,2-dioleoylglycerol, and 30 /¿M [3H]palmitoyl-CoA 
for 10 min at room temperature (18).
GPAT Protein Expression—Proteins were separated by SDS-poly- 
acrylamide gel electrophoresis and transferred to a polyvinylidene di­
fluoride membrane, which was probed with anti-FLAG M2 antibody 
(Sigma), washed extensively, and then probed with horseradish perox- 
idase-conj ugated goat anti-mouse IgG (Pierce). GPAT-FLAG protein 
was visualized by a reaction with Supersignal chemiluminescent sub­
strate (Pierce) and exposed to x-ray film.
Cell Radiolabeling and Lipid Analysis—CHO cells (stably overex­
pressing GPAT) were seeded in 60-mm dishes, grown to near confluence 
in the continuous presence or absence of 2 gg/ml doxycycline, and 
incubated with either trace (~3 /¿m) or 100 /¿M [14C]oleic acid (0.25 
/¿Ci/dish) in medium supplemented with 0.5% BSA. HEK293 (human 
embryonic kidney) cells in 60-mm dishes were transfected with 
pcDNA3.1-GPAT-FLAG or pcDNAS.l (control) for 18 h, then incubated 
with trace (~3 /¿m) [14C]oleic acid (0.25 /¿Ci/dish) in medium supple­
mented with 0.5% BSA. At various time points, the medium was re­
moved, and the cells were washed with 0.1% BSA in ice-cold PBS 
scraped in ice-cold methanol and H2O. Total lipids were extracted (19) 
and concentrated in a Savant SpeedVac concentrator. Neutral lipids 
were resolved by TLC using a solvent system consisting of hexane: 
ethylether:acetic acid (80:20:1; v/v). Phospholipid species were sepa­
rated by TLC in a one-dimensional solvent system of chloroform:meth- 
anoLacetic acid: water (50:37.5:3.5:1.5; v/v). All samples were 
chromatographed in parallel with pure lipid standards. The 14C-labeled 
lipids were detected using a Bioscan Image System.
Determination of SREBP-1 and PPARy Levels—Cell monolayers at 
80% confluence were scraped from the dishes, washed twice with ice-
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To determine whether increased mitochondrial GPAT ex­
pression resulted in secondary effects on related enzymes of 
glycerolipid synthesis, we measured activities of microsomal 
GPAT, acyl-CoA synthetase, and diacylglycerol acyltransferase 
in total particulate preparations from the Tet-Off CHO cells 
grown with (control) or without (GPAT overexpressing) doxy­
cycline (Table I). Mitochondrial GPAT specific activity was 
3.8-fold higher in the overexpressing cells compared with con­
trols, but no changes were observed in the specific activities of 
the other enzymes.
GPAT-overexpressing CHO Cells Contain More Triacylglyc­
erol—GPAT-overexpressing CHO cells in medium without 
added fatty acid contained 2.7-fold more triacylglycerol mass 
than control cells (Fig. 2). When the cells were incubated with 
100 p,M oleate to stimulate triacylglycerol accumulation, both 
groups of cells increased their neutral lipid content at similar 
rates throughout the 24-h incubation time, but the mass of 
triacylglycerol was always greater in the GPAT overexpress­
ing cells (3.1-, 2.2-, and 1.6-fold higher at 3, 6, and 24 h, 
respectively).
GPAT Expressed in CHO Cells Is Targeted to Mitochondria— 
Because the final steps in the enzyme pathway that synthe­
sizes triacylglycerol are located in the endoplasmic reticulum, 
it was surprising to find that overexpression of a mitochondrial 
enzyme resulted in excess triacylglycerol content. Thus, we 
wondered whether GPAT might be overexpressed in an aber­
rant location that could provide LPA directly for triacylglycerol 
biosynthesis. Because the EGFP expressed by GPAT overex­
pressing CHO cells would interfere with FITC excitation at 488 
nM, we studied CHO cells that had been transiently transfected 
with an identical GPAT-FLAG construct. Mitochondrial GPAT 
activity at 28 h after transfection increased from 0.14 to 0.86 
nmol/min/mg of protein. Anti-FLAG indirect antibody staining 
recognized the expressed GPAT (Fig. 3b) and matched the 
specific mitochondrial marker signal (Fig. 3, c and d). Both the 
cells transfected with the empty vector and those that had not 
been exposed to the first antibody emitted fluorescence in the 
FITC band only at background levels. Thus, FITC staining was 
not due to nonspecific binding of the anti-FLAG antibody to 
mitochondria. When the overlapping image (Fig. 3d) was sub­
tracted from the GPAT localization image (Fig. 3b) using Bool­
ean operator transformation, the resulting image was com­
pletely dark, indicating that GPAT was present only in 
mitochondria and not in other locations.
GPAT-overexpressing CHO Cells Synthesize Excess 
[14C]Triacylglycerol—Because GPAT-overexpressing CHO 
cells accumulated more triacylglycerol mass, we measured the 
ongoing rate of triacylglycerol formation in the absence of 
added medium fatty acid. Cells were incubated with tracer 
amounts (~3 p.M) of [14C] oleic acid for up to 24 h. Cells that 
overexpressed GPAT showed a significantly higher incorpora­
tion of [14C]oleate into triacylglycerol (2.7-, 2.5-, and 3.4-fold 
higher at 3, 6, and 24 h, respectively) compared with control 
cells (Fig. 4A). Overexpression of GPAT did not affect [14C]oleic 
acid incorporation into cholesterol esters (Fig. 4B).
Fig. 1. Time course of mitochondrial GPAT expression and 
activity in Tet-Off cells transfected with pBI-EGFP/GPAT- 
FLAG. After growing routinely in the presence of 2 gg/ml doxycycline, 
cells in 100-nim dishes were placed in media without doxycycline. At 
the intervals shown, cells from each dish were scraped, homogenized, 
and centrifuged to obtain total particulate preparations for measure­
ment of mitochondrial GPAT expression (with M2 anti-Flag antibody) 
(A) and specific activity (B).
cold PBS, resuspended in 0.25 M sucrose, 1 mM EDTA, 1 mg/ml protease 
inhibitor mixture (Sigma), and 10 mM Tris buffer, pH 7.4, and disrupted 
by several passages through a 22-gauge syringe needle. Proteins from 
total membranes from GPAT overexpressing CHO cells and controls 
were separated in SDS-PAGE and blotted onto nitrocellulose mem­
branes. Immunoblots were performed using the corresponding poly­
clonal antibody against full-length (128 kDa) and mature (68 kDa) 
SREBP-1 and PPAR-y (Santa Cruz Biotechnologies). Anti-rabbit horse­
radish peroxidase-conjugated antibody was used as secondary antibody. 
Immunoreactive bands were detected using a chemiluminescence de­
tection kit (Pierce).
Other Measurements—Protein was measured using serum bovine 
albumin as the standard (20). Triacylglycerol was measured using a 
TGO-Trinder kit (Sigma), and phospholipid was measured by phos­
phate analysis (21). Distribution of [14C]oleate in the sn-1 and sn-2 
positions of phospholipids was examined by phospholipase A2 iNaja 
naja) (Sigma) hydrolysis of phospholipids labeled for 48 h with 
[14C]oleate as described previously (22). Lipids extracts were chromato­
graphed with hexane/ethyl ether/acetic acid (80:20:1; v/v) to separate 
unesterified fatty acids from total polar lipids and counted in the 
Bioscan Image System. Data are presented as means ± S.D. Differences 
between the transfected cell lines and the controls were analyzed by 
Student’s t test.
RESULTS
A stable Tet-Off CHO cell line was constructed that ex­
pressed both EGFP and mitochondrial GPAT with a FLAG- 
epitope at the C terminus. EGFP was used to ensure that every 
cell expressed the construct. When cells were grown in the 
absence of doxycycline, fluorescence microscopy showed expres­
sion of both EGFP and the GPAT-FLAG epitope in every cell; 
no fluorescence was observed when 2 p-g/ml doxycycline was 
present (data not shown). Withdrawing doxycycline from the 
medium resulted in expression of GPAT protein at 6 days and 
a 3.3-fold increase in GPAT specific activity over the endoge­
nous basal activity (Fig. 1). Adding doxycycline to the medium 
repressed GPAT activity and protein expression within 24 h, 
suggesting that GPAT protein is rapidly degraded (data not 
shown). A dose response showed that plasmid-mediated GPAT 
expression (ascertained by Western blot analysis of the FLAG 
epitope) was nearly completely blocked when as little as 0.05 
jag/ml doxycycline was present in the medium for 24 h.
Synthesis of[14C]Phospholipid in GPAT-overexpressing CHO 
Cells—Not only is GPAT the committed step for triacylglycerol 
synthesis, but it is also required for the synthesis of all the 
glycerophospholipids. Therefore we examined ongoing incorpo­
ration of low amounts of [14C]oleate (~3 p-M) into the different 
phospholipid species in the GPAT-overexpressing CHO cells 
and in controls (Fig. 5). At each time point up to 24 h, GPAT 
overexpressing cells showed 30% decreased incorporation of 
[14C] oleate into total phospholipids. [14C] Oleate-labeled phos­
phatidylcholine decreased 30-35% and [14C]PI plus [14C]phos- 
phatidylserine decreased 40-50%, but [14C]phosphatidyleth-
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Table I
Glycerolipid synthetic activities in control cells and cells that over-express mitochondrial GPAT
Mitochondrial GPAT, microsomal GPAT, acyl-CoA synthetase, and diacylglycerol acyltransferase were assayed as described under “Experimen­
tal Procedures” in three independent total particulate preparations from cells that were grown continuously with (control) or without (GPAT) 
doxycycline. Data are expressed as mean ± S.D. Numbers in parentheses represent the percent of total GPAT specific activity.
Mitochondrial GPAT Microsomal GPAT Acyl-CoA synthetase Di acyl glycerol acyltransferase
nmol ! min ! mg protein
Control 0.11 ± 0.01 0.85 ± 0.22 11.0 ± 2.5 0.37 ± 0.03
( +doxycycline) 11% (89%)
GPAT 0.42 ± 0.09“ 0.62 ± 0.26 10.7 ± 3.1 0.36 ± 0.01
( - doxycycline) (40%4 (60%)
a p < 0.01 compared to control.
Time (h)
Time (h)
Fig. 2. GPAT overexpression promotes triacylglycerol accu­
mulation in CHO cells. Preconfluent CHO cells were grown in MEM 
10% FBS in the presence (Control) or absence (GPAT) of 2 gg/ml 
doxycycline. At time 0 they were supplemented with 100 gM sodium 
oleate for up to 24 h. Cells were collected, homogenized, and extracted 
as described under “Experimental Procedures.” Total cell triacylglyc­
erol was measured at the intervals shown. Values represents the 
means ± S.D. for three 100-mm dishes. Some error bars are hidden by 
the symbols.
D
ow
nloaded from http: w
w
w
.jbc.org by guest on A
ugust 23. 2019
HEK293 cells (e-h) were transiently transfected with GPAT-FLAG for 
27 h and stained as described under “Experimental Procedures.” a and 
e, phase-contrast microscopy; b and/, anti-FLAG primary antibody and 
FITC-conjugated secondary antibody; c andg, Texas Red Mito-Tracker; 
d and h, overlapped image of b and c or/and g. The scale bars represent 
10 gm. The figure is representative of three to four independent trans­
fections for each cell line.
Time (h)
FiG. 4. GPAT overexpression stimulates incorporation of 
[MC]oleate into triacylgiycerol but not cholesterol ester. Nearly 
confluent CHO cells, maintained in 10% FBS, MEM in the presence 
(Control) or absence (GPAT) of 2 gg/ml doxycycline, were incubated 
with 0.25 gCi of [14C]oleic acid/dish in the same media plus 0.5% BSA 
for up to 24 h. Lipids were extracted and separated as described under 
“Experimental Procedures.” Data points represent the means ± S.D. of 
an experiment performed in triplicate. Some error bars are hidden by 
the symbols. A, [14C] triacylgiycerol; B, [14C]cholesterol ester. **,  p < 
0.01; ***,  p < 0.005 compared with the control.
anolamine decreased relatively little (15%). Viewed as a whole, 
the control cells incorporated 4.7 times more label into phos­
pholipid than triacylglycerol, but the GPAT overexpressing 
cells incorporated the 14C label equally into the two lipid spe­
cies. With trace [14C] oleate plus 10% FBS (which contains 
21—28 /xM fatty acid (7)), the cells are exposed to medium that
contains —30 gM fatty acid. Thus, the incorporation data are 
surprising, because normally with concentrations of media 
oleate of less than 30 gM, four to five times more label is 
incorporated into phospholipid than triacylgiycerol, as occurred 
in the control cells. To enable radiolabel to be distributed 
equally in the two lipid fractions in fibroblasts, total media 
oleate concentrations must be greater than 60 gM (8).
Phospholipid Synthesis Was Not Impaired in GPAT-overex- 
pressing CHO Cells—Diminished incorporation of [14C]oleate 
into phospholipid could result from a decrease in the rate of
GPAT Directs Triacylglycerol Synthesis 42209
Time (h)
Time (h)
phospholipid synthesis or because exogenously added fatty ac­
ids are incorporated preferentially into triacylglycerol rather 
than phospholipid. We examined these possibilities by compar­
ing the rate of cell division of control CHO cells and CHO cells 
that overexpressed GPAT. The rate of growth was identical for 
the two cell types (Fig. 6), phospholipid content was 0.42, 0.34, 
and 0.28 pg/pg of protein in GPAT, control, and vector-trans­
fected cells, respectively, and these differences were not statis­
tically significant. Thus, phospholipid synthesis and accretion 
appeared to be unaffected despite the diminished incorporation 
of [14C] oleate. Because mitochondrial GPAT prefers saturated 
over unsaturated fatty acids, it has been hypothesized that one 
of the enzyme’s functions might be to direct the incorporation of 
saturated fatty acids into the S71-1 position of phospholipids (4). 
To test this idea, GPAT overexpressing and control cells were 
incubated with [14C] oleate (~3 p,M). After 48 h total lipids were 
extracted and treated with phospholipase Ag, which hydrolyzes 
the fatty acid at the sn-2 position of phospholipids. The 
[14C]oleate content of hydrolyzed (sn-2 fatty acids) and nonhy­
drolyzed (sii-1 acyl-lysophospholipid) was quantified. In both 
GPAT-overexpressing and control cells, 70% of the label was 
released, showing that there had been equivalent incorporation 
of oleate (30%) at the S71-1 position in control and GPAT over­
expressing cells. This study indicates that a 3.8-fold increase in 
GPAT specific activity did not affect the positional distribution 
of a monounsaturated fatty acid.
Fig. 5. GPAT overexpression inhibits incorporation of [14C]oleate into phospholipid. Nearly confluent CHO cells grown in 10%' FBS, 
MEM plus (Control) or minus (GPAT) 2 gg/ml doxycycline were labeled with 0.25 gCi of [14C]oleic acid/dish in the same media for up to 24 h. At 
each time point, cell lipids were extracted, and polar lipid species were separated by TLC. Each value corresponds to the mean ± S.D. of an 
experiment performed in triplicate. Some error bars are smaller than the symbols. A, 14C-labeled total phospholipids; B, [14C] phosphatidylcholine; 
C, [14C]phosphatidylethanolamine; and D, [14C]phosphatidylinositol (PI) plus phosphatidylserine (PS). *, p < 0.05; **, p < 0.01; ***, p < 0.005 
compared with the control.
Fig. 6. Growth rate was identical in control and GPAT-over- 
expressing cells. pBI-EGFP/GPAT-FLAG CHO cells were grown in 
the presence or absence of 2 gg/ml doxycycline. At time 0, cells growing 
in the presence or absence of doxycycline were trypsinized and plated in 
35-mm plates (10,000 cells/dish) in the continued presence (Control) or 
absence (GPAT) of doxycycline. Cells were trypsinized and counted at 
24, 48, and 72 h. Data are expressed as means ± S.D. of three dishes for 
each time point.
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Incorporation of [14C]0leic Acid into Triacylglycerol and 
Phospholipids in the Presence of 100 pu Oleate—As shown in 
Figs. 4 and 5, when a low concentration of fatty acid was
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Time (h)
Fig. 7. Fatty acid enhances incorporation of [14C]oleic acid 
into triacylglycerol by overexpressed GPAT. Cells were incubated 
with 0.25 /rCi of [14C]oleic acid/dish in 0.5%' BSA, 10%' FBS, MEM plus 
100 /xM sodium oleate for up to 24 h. At each time point total lipids were 
extracted from the cells and separated by TLC. Values represent the 
means ± S.D. of three experiments. Some error bars are hidden by the 
symbols. A, [14C]triacylglycerol; B, [14C]phospholipid. *,p < 0.05; ***, 
p < 0.005 compared with the control.
present in the media, GPAT overexpression in CHO cells 
greatly enhanced the incorporation of [14C] oleate into triacyl­
glycerol while concomitantly decreasing incorporation into 
phospholipid. We next asked whether this pattern of lipid syn­
thesis in CHO cells overexpressing GPAT would be altered if 
the media contained the high concentration of fatty acid com­
monly used in experiments designed to promote triacylglycerol 
synthesis and accumulation in cultured cells. When the forma­
tion of newly synthesized [14C] triacylglycerol was measured in 
the presence of 100 /xM [14C] oleate, the incorporation of 
[14C] oleate into triacylglycerol was only 1.3-fold higher in the 
GPAT-overexpressing cells compared with control cells (Fig. 
7A), and similar amounts of label were incorporated into phos­
pholipid in the control and overexpressing cells (Fig. 7B). When 
100 /xM oleate was present, the ratio of triacylglycerol to phos­
pholipid was 2.6 to 1 in GPAT-overexpressing cells compared 
with 1.9 to 1 in control cells (Table II). Thus, whether oleate 
availability was high or low, GPAT overexpression promoted 
incorporation of exogenous oleate into triacylglycerol.
Incorporation of [14C]0leate by Transiently Transfected 
HEK293 Cells—HEK293 cells transiently transfected with 
pcDNA3.1-GPAT-FLAG showed maximum mitochondrial GPAT 
protein expression and activity between 18 and 36 h after 
transfection with a 30% decline by 48 h. At 24 h after trans­
fection, mitochondrial GPAT specific activity was 0.33 nmol/ 
min/mg of protein, a 4.4-fold increase compared with the con­
trol cells (0.074 nmol/min/mg of protein), and the GPAT- 
overexpressing cells and the control cells contained similar 
amounts of triacylglycerol and phospholipid (data not shown). 
Confocal microscopy showed that mitochondrial GPAT was 
present only in mitochondria (Fig. 3, e-h). From 18 to 42 h after 
transfection, incorporation of trace [14C] oleate (~3 /xm) into 
TAG was 9.7-fold higher in the GPAT-overexpressing cells than 
the controls (Fig. 8A). Unlike the stably overexpressing CHO 
cells, the transiently transfected line also incorporated more 
label into phospholipid (19.6 x 105 dpm/mg of protein in GPAT 
overexpressers versus 6.8 x 105 dpm/mg of protein in control 
cells) (Fig. 8B) and more in cholesterol esters (7.6 x 104 
dpm/mg of protein in GPAT overexpressers versus 3.4 x 104 
dpm/mg of protein in control cells). It is likely that the high rate 
of label incorporation into phospholipid in the transiently 
transfected HEK293 cells occurred, because only a small num­
ber of the HEK293 cells actually expressed the GPAT con­
struct. Nevertheless, the ratios of label incorporated into tria­
cylglycerol versus phospholipid were 1:12.4 in the control cells 
and only 1:3.7 in the GPAT-overexpressing cells, again showing 
the decisive effect of mitochondrial GPAT expression on the 
synthesis of triacylglycerol relative to phospholipid.
The Transcription Factors SREBP-1 and PPARy Are Unaf­
fected in GPAT Overexpressing CHO Cells—SREBP-1 and 
PPARy are well known transcriptional factors that stimulate 
lipogenesis by increasing the levels of lipid synthetic enzymes. 
Since the effects of GPAT overexpression on lipid metabolism 
could be secondary to up-regulation of these lipogenic factors, 
or since the transcription factors might be down-regulated by 
the excess triacylglycerol mass in GPAT-overexpressing cells, 
we determined the levels of both SREBP-1 and PPARy in 
control and GPAT-overexpressing CHO cells. No changes in the 
amount of full-length or mature SREBP-1 or in PPARy levels 
were detected in GPAT overexpressers when compared with 
controls (data not shown).
DISCUSSION
The regulation of triacylglycerol synthesis remains poorly 
understood, in large part, because molecular tools have only 
recently become available for several of the enzymes in the 
triacylglycerol synthetic pathway (4). Enzyme isoforms have 
been identified for most of the steps in the pathway, but the 
separate role of each isoform has not yet been delineated for 
any glycerolipid synthetic enzyme. For GPAT, only the mito­
chondrial isoform has been cloned (23, 24), but the microsomal 
activity can be distinguished by its sensitivity to sulfhydryl 
reagents like N-ethylmaleimide (4). High carbohydrate feeding 
and insulin increase the mitochondrial GPAT activity and 
mRNA in liver, but have little effect on the microsomal activity 
(4, 10). Mitochondrial GPAT is up-regulated transcriptionally 
during adipocyte differentiation (11, 25) and probably during 
neonatal liver development (26). The mitochondrial GPAT pro­
moter contains carbohydrate-responsive sequences and sterol 
regulatory element sites (11, 27), and SREBP-lc mRNA is 
up-regulated by insulin (12). Purified recombinant AMP-acti- 
vated kinase also acutely decreases mitochondrial, but not 
microsomal GPAT activity in isolated membrane fractions from 
hepatocytes, suggesting that phosphorylation acutely de­
creases GPAT activity when cell ATP levels are low, thereby 
diminishing glycerolipid synthesis (14).
In most tissues and in cultured cells, mitochondrial GPAT 
comprises only 10% of total GPAT activity, and its role has 
remained obscure. It has been proposed that mitochondrial
D
ow
nloaded from http://w
vvvv.jbc.org by guest on A
ugust 23. 2019
GPAT Directs Triacylglycerol Synthesis 42211
Table II 
Relative incorporation of oleate into phospholipid and triacylglycerol
Data are derived from the 24-h experiments shown in Figs. 4, 5, and 7 and expressed as means ± S.D. TAG, triacylglycerol; PL, phospholipid.
Added oleate Cell line Tri acyl glycerol Phospholipid Ratio TAG:PL
/-ÜW dpm / mg protein
3 Control (+doxycycline) 91,378 ± 3,633 425,548 ± 8,772 1:4.7
3 GPAT (-doxycycline) 310,534 ± 18,516 287,773 ± 16,068 1:1
100 Control (,+doxycycline) 258,601 ± 8,913 136,068 ± 3,402 1.9:1
100 GPAT (-doxycycline) 332,278 ± 4,246 126,534 ± 5,519 2.6:1
Fig. 8. GPAT overexpression in HEK293 cells stimulates incor­
poration of [14C]oleate into triacylglycerol and phospholipid. 
HEK293 cells, maintained in 10% FBS, MEM, were transfected with 
pcDNA3.1-GPAT-FLAG (GPAT) or pcDNA3.1 (Control) for 18 h, then 
incubated with 0.25 gCi of [14C]oleic acid/dish in the same media plus 
0.5%' BSA for 6 or 24 h. Lipids were extracted and separated as de­
scribed under “Experimental Procedures.” Data points represent the 
means ± S.D. of an experiment performed in triplicate that was re­
peated three times. Some error bars are hidden by the symbols. ***, p < 
0.005 compared with the control.
GPAT provides precursors for phosphatidylglycerol and cardio­
lipin and that it increases the saturated fatty acid content at 
the S71-1 position of phospholipids (4). In liver the mitochondrial 
isoform comprises 50% of total activity, and its mRNA is mark­
edly up-regulated by insulin, suggesting a strong relationship 
with lipogenesis and triacylglycerol synthesis. Although up­
regulation of GPAT activity might be expected for a cell faced 
with marked increases in its fatty acid content, one might 
predict that regulation of triacylglycerol synthesis would in­
volve the microsomal rather than the mitochondrial isoform, 
because the specific activity of the microsomal isoform in­
creases 70-fold during both adipocyte differentiation (16) and 
postnatally when the rat pup’s primary energy source changes 
from glucose to lipid (26). Furthermore, the microsomal isoform 
is located on the endoplasmic reticulum where the terminal 
steps in triacylglycerol synthesis take place (4). Our studies, 
however, support the view that mitochondrial GPAT controls 
the entry of exogenously derived fatty acids into triacylglycerol 
stores. CHO cells, which normally contain little mitochondrial 
GPAT, accumulate triacylglycerol when mitochondrial GPAT 
expression is increased 3.8-fold, from 11 to 40% of total GPAT 
specific activity.
Thus, our finding that overexpressing mitochondrial GPAT 
directs incorporation of fatty acids into triacylglycerol in pref­
erence to phospholipid is surprising, because GPAT is the first 
step in a complex pathway that has redundant isoenzymes and 
two major branch points. With low concentrations of fatty acid 
substrate in the media, CHO and HEK293 cells that overex­
press GPAT incorporated 3-fold and 9.7-fold more labeled 
oleate into triacylglycerol, respectively, than did control CHO 
cells in which doxycycline suppressed GPAT expression or 
HEK293 cells in which only the pcDNA3.1 vector was present. 
Furthermore, CHO cells that stably overexpressed GPAT in­
corporated equal amounts of [14C] oleate into triacylglycerol 
and phospholipid, even though the amount of fatty acid pro­
vided in the media was present at a concentration that usually 
promotes the incorporation of fatty acid primarily into phos­
pholipid (7, 8, 28), and, as expected, the control CHO cells 
incubated with low concentrations of [14C] oleate incorporated 
4.7-fold more label into phospholipid. Control HEK293 cells 
incubated with a low concentration of [14C] oleate incorporated 
12.4-fold more label into phospholipid than triacylglycerol, but 
transient transfection of the HEK293 cells with GPAT lowered 
this ratio to 1:3.4. At 100 p,M oleate ( — 120 p.M fatty acid, 
including the contribution from FBS), the effect of overex­
pressed GPAT was still evident in CHO cells, and more oleate 
was incorporated into triacylglycerol than was seen with con­
trol cells, thereby confirming that triacylglycerol synthesis is 
not driven solely by the amount of available fatty acid. These 
data indicate that GPAT does not merely promote fatty acid 
uptake and entry into the pathway of glycerolipid synthesis. If 
increased flux were GPAT’s sole contribution, one would expect 
equally enhanced [14C] oleate incorporation into phospholipid 
and triacylglycerol in the GPAT overexpressing cells. Instead, 
cells incorporated label preferentially in triacylglycerol, both at 
low and high media fatty acid concentrations. We hypothesize 
that because only a fraction of the HEK293 cells were trans­
fected, the nontransfected cells incorporated oleate into phos­
pholipid at the high rate that is usually observed in the pres­
ence of low amounts of exogenous fatty acid (7, 8). Even so, the 
presence of GPAT promoted an increase in oleate incorporation 
into triacylglycerol that was more than three times greater 
than into phospholipid.
Triacylglycerol is stored in cells as cytosolic lipid droplets, 
which also contain cholesterol esters. It is not known whether 
the synthetic pathways for both of these neutral lipids are 
co-regulated. Our results clearly show, however, that when 
triacylglycerol mass and the rate of incorporation of labeled 
fatty acid into triacylglycerol increase severalfold in CHO cells, 
the incorporation of label into cholesterol ester is unaffected 
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(Fig. 4, A and B), and cholesterol ester mass is unchanged ( data 
not shown), but that incorporation into cholesterol ester in­
creases in HEK293 cells. Thus, triacylglycerol and cholesterol 
ester pathways may not share the same pool of activated fatty 
acid in CHO cells. Similarly, when CHO cells are treated with 
phospholipase C, their pool of cytosolic triacylglycerol expands, 
but the cellular content of cholesterol ester does not change 
(29). Results from the HEK293 cells, however, suggest the 
possibility that access to activated fatty acid pools may differ in 
different cell types, perhaps related to the presence of ACAT1 
versus ACAT2.
Overexpression of GPAT decreases the incorporation of ex­
ternally provided fatty acid into phosphatidylcholine and phos­
phatidylinositol plus phosphatidylserine while having little ef­
fect on phosphatidylethanolamine. Preferential use of oleate 
for phosphatidylethanolamine rather than phosphatidylcho­
line synthesis is also observed in fetal human fibroblasts when 
oleate is scarce (7).
The present study extends the concept that GPAT controls 
glycerolipid synthesis by raising additional questions related to 
the independent functions of the two GPAT isoforms and to the 
trafficking of lipid intermediates within cells. Because mito­
chondrial GPAT and LPA acyltransferase are both present on 
the mitochondrial outer membrane, their LPA and/or phospha- 
tidic acid products must be transported to the endoplasmic 
reticulum where the final steps occur in the synthesis of both 
triacylglycerol and most of the major phospholipids. Although 
the liver isoform of fatty acid-binding protein is reported to 
transport LPA (30), LPA and phosphatidic acid should diffuse 
through the cytosol as readily as lysophosphatidylcholine, be­
cause the energy of the membrane off-rate of the acyl group is 
the major barrier (31). Alternatively, there may be membrane 
contact regions between the mitochondrial outer membrane 
and the endoplasmic reticulum that could facilitate the trans­
port of pathway intermediates.
More difficult to understand is the mechanism by which 
mitochondrial synthesis of LPA could direct this intermediate 
toward LPA acyltransferase and phosphatidic acid phosphohy­
drolase that link primarily with DGAT and triacylglycerol syn­
thesis while providing little phosphatidic acid or diacylglycerol 
substrate that can be used by enzymes of phospholipid synthe­
sis. Use of oleate rather than other fatty acids should not 
present a problem, because when triacylglycerol synthesis is 
promoted by incubating cells with 100 p,M [14C] oleate, incorpo­
ration of radiolabel into phospholipid remains stable (7, 8). 
Thus, oleate-containing LPA and phosphatidic acid are excel­
lent substrates for phospholipid synthesis. Instead, the current 
data suggest the possibility that mechanisms exist within the 
endoplasmic reticulum to channel lipid intermediates toward 
independent pathways. Studies of fibroblasts from a patient 
with neutral lipid storage disease indicated that de novo and 
recycling pools of diacylglycerol did not mix (32), and strong 
evidence was presented in fibroblasts and hepatocytes for func­
tionally separate pools of acyl-CoA (22, 33).
The apparent reciprocal regulation of carnitine palmitoyl­
transferase 1 and mitochondrial GPAT by AMP-activated ki­
nase has suggested that GPAT present on the mitochondrial 
outer membrane may compete for acyl-CoAs with carnitine 
palmitoyltransferase 1(14). Thus, an increase in mitochondrial 
GPAT activity might divert acyl-CoAs away from oxidation and 
toward glycerolipid synthesis. To test this hypothesis, further 
studies are needed in cells that perform a significant amount of 
ß-oxidation.
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